Study reveals why some depressed patients have blood inflammation

May 5, 2016
Study reveals why some depressed patients have blood inflammation

A new King's College London study reveals why some - but not all - people have depression that appears to be caused by blood inflammation.

These insights could help researchers to develop novel treatment strategies for the many depressed who do not get better using current antidepressants.

Recent research suggests that patients with depression have measurable changes in the blood that indicate activation of the inflammatory system - a biological response which is predominantly directed to fight infection but which also has an important role in regulating mood and behaviour.

Blood is known to worsen in the brain, which occurs when the body both overproduces and then struggles to remove molecules called 'free radicals.' These free radicals break down brain connections and disrupt the brain's chemical signalling, which in turn can lead to the development of by reducing the brain's protective mechanisms.

This new King's research, published in Neuropsychopharmacology, indicates that some depressed patients are predisposed to develop depression when their inflammatory system is activated because they are more 'biologically sensitive' to inflammation. As a result, their brains are more likely to suffer.

Researchers have known for many years that approximately one third of patients who take an anti-viral immune drug called 'interferon-alpha' develop depression, because this drug activates the inflammatory system. The King's College London research team set out to study patients taking interferon-alpha as a model for inflammation-induced depression, in order to dissect the mechanisms through which an activated inflammatory system causes depressive symptoms in some but not all individuals.

They measured the activation of multiple biological systems in the blood of 58 patients before and after the inflammatory activation with interferon-alpha, and correlated changes in these systems with the onset of depressive symptoms.

The researchers found that patients who developed depressive symptoms following the inflammatory activation tended to be more biologically sensitive to interferon-alpha. Specifically, they had a more reactive inflammatory system, and also showed more changes in biological systems involved in oxidative stress and in the protection of brain cells.

Dr Nilay Hepgul, lead author of the study from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London, said: 'Our results are important not only for understanding the high prevalence of depression amongst individuals receiving interferon-alpha treatment, but also to identify those at risk of developing in the context of high inflammation due to other causes, such as severe stress or medical illnesses.'

Professor Carmine Pariante, senior author of the study from the IoPPN at King's College London, said: 'Both oxidative stress and brain protective mechanisms can be considered future targets for the development of novel, effective antidepressant strategies, especially for patients with high levels of inflammation who do not get better using current antidepressants.'

Professor Pariante added: 'Our next aim is to understand the implications of this increased inflammation in the blood and whether it has direct consequences for the brain, using neuroimaging techniques.

'We also need to understand why some patients are more biologically sensitive to increased inflammation. Do they have a specific genetic profile that makes them more susceptible, or has exposure to stress life events had an impact - or both?'

Explore further: Inflammation attacks brain's reward center

More information: Nilay Hepgul et al. Transcriptomics in Interferon-α-Treated Patients Identifies Inflammation-, Neuroplasticity- and Oxidative Stress-Related Signatures as Predictors and Correlates of Depression, Neuropsychopharmacology (2016). DOI: 10.1038/npp.2016.50

Related Stories

Inflammation attacks brain's reward center

February 2, 2016

A new study by Neil Harrison and colleagues published in Biological Psychiatry suggests that a brain reward center, the striatum, may be directly affected by inflammation and that striatal change is related to the emergence ...

Omega-3 fatty acids may prevent some forms of depression

October 1, 2014

Patients with increased inflammation, including those receiving cytokines for medical treatment, have a greatly increased risk of depression. For example, a 6-month treatment course of interferon-alpha therapy for chronic ...

Uncovering the source of inflammatory malaise

October 22, 2012

(Medical Xpress)—A study conducted by researchers at Emory indicates that inflammation targets a part of the brain called the basal ganglia, causing symptoms of depression and fatigue. The study was recently reported in ...

Inflammation markers could guide depression treatments

January 12, 2016

Psychiatrists investigating depression have been energized in recent years by reports of rapid, successful treatment with drugs that interfere with the brain chemical glutamate, such as the anesthetic ketamine.

Recommended for you

Research breakthrough in treating anxiety and depression

March 22, 2017

Pioneered by researchers at Monash University, a promising new, 'whole person' approach to the treatment of anxiety and depression has been developed in an effort to improve the effectiveness and efficiency of current treatment, ...

Mouse study identifies new method for treating depression

March 21, 2017

Standard antidepressant medications don't work for everyone, and even when they do they are slow to kick in. In an effort to find better depression treatments, researchers at University of California San Diego School of Medicine ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.